These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
201 related articles for article (PubMed ID: 7867757)
1. Cholecystokinin facilitates methamphetamine-induced dopamine overflow in rat striatum and fetal ventral mesencephalic grafts. Wang Y; Perng SL; Lin JC; Tsao WL Exp Neurol; 1994 Dec; 130(2):279-87. PubMed ID: 7867757 [TBL] [Abstract][Full Text] [Related]
2. Restoration of dopamine overflow and clearance from the 6-hydroxydopamine lesioned rat striatum reinnervated by fetal mesencephalic grafts. Wang Y; Wang SD; Lin SZ; Liu JC J Pharmacol Exp Ther; 1994 Aug; 270(2):814-21. PubMed ID: 7915321 [TBL] [Abstract][Full Text] [Related]
3. Electrochemical studies of the effects of substance P on dopamine terminals in the rat striatum. Tang FI; Chiu TH; Wang Y Exp Neurol; 1998 Jul; 152(1):41-9. PubMed ID: 9682011 [TBL] [Abstract][Full Text] [Related]
4. Intranigral ventral mesencephalic grafts and nigrostriatal injections of glial cell line-derived neurotrophic factor restore dopamine release in the striatum of 6-hydroxydopamine-lesioned rats. Tang FI; Tien LT; Zhou FC; Hoffer BJ; Wang Y Exp Brain Res; 1998 Apr; 119(3):287-96. PubMed ID: 9551829 [TBL] [Abstract][Full Text] [Related]
5. Human ventromesencephalic grafts restore dopamine release and clearance in hemiparkinsonian rats. Wang Y; Lin JC; Chiou AL; Liu JY; Liu JC; Zhou FC Exp Neurol; 1995 Dec; 136(2):98-106. PubMed ID: 7498419 [TBL] [Abstract][Full Text] [Related]
7. In vivo electrochemical measurements of exogenous dopamine clearance in normal and neonatal 6-hydroxydopamine-treated rat striatum. Luthman J; Friedemann MN; Hoffer BJ; Gerhardt GA Exp Neurol; 1993 Aug; 122(2):273-82. PubMed ID: 8405264 [TBL] [Abstract][Full Text] [Related]
8. Walking pattern analysis after unilateral 6-OHDA lesion and transplantation of foetal dopaminergic progenitor cells in rats. Klein A; Wessolleck J; Papazoglou A; Metz GA; Nikkhah G Behav Brain Res; 2009 May; 199(2):317-25. PubMed ID: 19124044 [TBL] [Abstract][Full Text] [Related]
9. Reversal of behavioural abnormalities by fetal allografts in a novel rat model of striatonigral degeneration. Wenning GK; Granata R; Laboyrie PM; Quinn NP; Jenner P; Marsden CD Mov Disord; 1996 Sep; 11(5):522-32. PubMed ID: 8866493 [TBL] [Abstract][Full Text] [Related]
10. Differential sensitivity of dopamine release and clearance to 6-hydroxydopamine lesioning in rat striatum. Wang Y; Tang FI; Chiou AL; Wang JY Life Sci; 1996; 59(21):1783-92. PubMed ID: 8937505 [TBL] [Abstract][Full Text] [Related]
11. Transplantation of mesencephalic cell suspension in dopamine-denervated striatum of the rat.I. Effects on spontaneous activity of striatal neurons. Di Loreto S; Florio T; Capozzo A; Napolitano A; Adorno D; Scarnati E Exp Neurol; 1996 Apr; 138(2):318-26. PubMed ID: 8620930 [TBL] [Abstract][Full Text] [Related]
12. [Experimental study of methamphetamine psychosis--role of glutamate and nitric oxide in methamphetamine-induced dopaminergic and serotonergic neurotoxicity in the rat brain]. Abekawa T Hokkaido Igaku Zasshi; 1997 Jan; 72(1):113-26. PubMed ID: 9086367 [TBL] [Abstract][Full Text] [Related]
13. Neurotrophic effects of bone morphogenetic protein-7 in a rat model of Parkinson's disease. Harvey BK; Mark A; Chou J; Chen GJ; Hoffer BJ; Wang Y Brain Res; 2004 Oct; 1022(1-2):88-95. PubMed ID: 15353217 [TBL] [Abstract][Full Text] [Related]
14. Mesencephalic neural stem (progenitor) cells develop to dopaminergic neurons more strongly in dopamine-depleted striatum than in intact striatum. Nishino H; Hida H; Takei N; Kumazaki M; Nakajima K; Baba H Exp Neurol; 2000 Jul; 164(1):209-14. PubMed ID: 10877931 [TBL] [Abstract][Full Text] [Related]
15. Clearance and diffusion of locally applied dopamine in normal and 6-hydroxydopamine-lesioned rat striatum. van Horne C; Hoffer BJ; Strömberg I; Gerhardt GA J Pharmacol Exp Ther; 1992 Dec; 263(3):1285-92. PubMed ID: 1469634 [TBL] [Abstract][Full Text] [Related]
16. Relationship between asymmetries in striatal dopamine release and the direction of amphetamine-induced rotation during the first week following a unilateral 6-OHDA lesion of the substantia nigra. Robinson TE; Noordhoorn M; Chan EM; Mocsary Z; Camp DM; Whishaw IQ Synapse; 1994 May; 17(1):16-25. PubMed ID: 8042143 [TBL] [Abstract][Full Text] [Related]
17. Dopaminergic transplants suppress L-DOPA-induced Fos expression in the dopamine-depleted striatum in a rat model of Parkinson's disease. Ishida Y; Kuwahara I; Todaka K; Hashiguchi H; Nishimori T; Mitsuyama Y Brain Res; 1996 Jul; 727(1-2):205-11. PubMed ID: 8842399 [TBL] [Abstract][Full Text] [Related]
18. Modulation of acetylcholine release by cholecystokinin in striatum: receptor specificity; role of dopaminergic neuronal activity. Petkova-Kirova P; Giovannini MG; Kalfin R; Rakovska A Brain Res Bull; 2012 Dec; 89(5-6):177-84. PubMed ID: 22981453 [TBL] [Abstract][Full Text] [Related]
19. Selective inhibition of cyclooxygenase-2 exacerbates methamphetamine-induced dopamine depletion in the striatum in rats. Zhang X; Dong F; Mayer GE; Bruch DC; Ren J; Culver B Neuroscience; 2007 Dec; 150(4):950-8. PubMed ID: 17988800 [TBL] [Abstract][Full Text] [Related]
20. Increased neuronal responsiveness to cholecystokinin and dopamine induced by lesioning mesolimbic dopaminergic neurons: an electrophysiological study in the rat. Debonnel G; de Montigny C Synapse; 1988; 2(5):537-45. PubMed ID: 2903570 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]